US Stock MarketDetailed Quotes

DRIO DarioHealth

Watchlist
  • 0.845
  • +0.015+1.80%
Close Nov 22 16:00 ET
28.80MMarket Cap-908P/E (TTM)

DarioHealth Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
111.00%7.42M
1.67%6.26M
-18.50%5.76M
-26.41%20.35M
-46.89%3.62M
-46.74%3.52M
-0.50%6.15M
-12.33%7.07M
34.82%27.66M
12.96%6.81M
Operating revenue
111.00%7.42M
1.67%6.26M
-18.50%5.76M
-26.41%20.35M
-46.89%3.62M
-46.74%3.52M
-0.50%6.15M
-12.33%7.07M
34.82%27.66M
12.96%6.81M
Cost of revenue
21.94%3.55M
-14.20%3.5M
-14.67%3.33M
-20.18%14.37M
-14.55%3.48M
-39.48%2.91M
-19.17%4.08M
-4.30%3.9M
8.77%18M
-25.60%4.08M
Gross profit
535.57%3.88M
32.88%2.76M
-23.23%2.43M
-38.02%5.98M
-95.17%132K
-66.11%610K
82.25%2.07M
-20.52%3.17M
143.63%9.66M
398.54%2.73M
Operating expense
-1.54%15.91M
17.73%18.95M
30.25%20.29M
-6.46%62.17M
22.19%14.35M
-1.33%16.16M
-12.97%16.09M
-21.56%15.58M
-17.39%66.47M
-47.14%11.74M
Selling and administrative expenses
-0.29%10.46M
11.64%12.14M
31.06%13.65M
-10.45%41.93M
45.85%10.15M
-9.33%10.49M
-24.27%10.87M
-25.26%10.41M
-25.97%46.82M
-58.81%6.96M
-Selling and marketing expense
5.81%6.73M
10.40%7.13M
8.99%6.91M
-21.56%23.79M
17.91%4.62M
-15.96%6.36M
-30.52%6.46M
-33.51%6.34M
-23.63%30.32M
-67.95%3.92M
-General and administrative expense
-9.69%3.73M
13.44%5.01M
65.44%6.74M
9.99%18.14M
81.88%5.53M
3.23%4.13M
-12.79%4.41M
-7.37%4.07M
-29.91%16.49M
-34.86%3.04M
Research and development costs
-3.87%5.45M
30.41%6.81M
28.60%6.64M
3.05%20.25M
-12.25%4.2M
17.95%5.67M
26.23%5.22M
-12.86%5.17M
14.11%19.65M
-10.05%4.78M
Operating profit
22.62%-12.03M
-15.49%-16.19M
-43.90%-17.86M
1.09%-56.19M
-57.77%-14.22M
-6.68%-15.55M
19.22%-14.02M
21.82%-12.41M
25.73%-56.81M
58.41%-9.01M
Net non-operating interest income expense
-68.28%-313K
200.62%2.58M
7.83%-530K
156.18%1.22M
394.39%4.78M
82.44%-186K
-281.70%-2.57M
-2,513.64%-575K
-5,342.50%-2.18M
-10,037.50%-1.62M
Non-operating interest income
----
----
16.42%390K
269.17%1.87M
69.06%470K
----
----
8,275.00%335K
1,050.00%506K
3,375.00%278K
Non-operating interest expense
----
----
----
--0
----
----
----
----
--1.88M
----
Total other finance cost
68.28%313K
-200.62%-2.58M
1.10%920K
-20.07%645K
-18,037.50%-4.31M
-82.44%186K
281.70%2.57M
3,400.00%910K
860.71%807K
0.00%24K
Other net income (expense)
5,732.91%9.22M
-37.32%-4.4M
-141.22%-4.78M
818.18%158K
-1,542.05%-3.2M
-1,660.63%-1.98M
Gain on sale of security
----
----
5,732.91%9.22M
-37.32%-4.4M
-141.22%-4.78M
----
----
818.18%158K
-1,542.05%-3.2M
-1,660.63%-1.98M
Income before tax
21.54%-12.34M
17.94%-13.61M
28.51%-9.17M
4.54%-59.36M
-12.75%-14.22M
-0.64%-15.73M
8.00%-16.59M
19.42%-12.83M
18.95%-62.19M
41.48%-12.61M
Income tax
-13K
0
-1.99M
1,500.00%64K
2,033.33%64K
0
0
0
-87.50%4K
-90.63%3K
Net income
21.62%-12.33M
17.94%-13.61M
44.05%-7.18M
4.45%-59.43M
-13.23%-14.29M
-0.64%-15.73M
8.00%-16.59M
19.42%-12.83M
18.98%-62.19M
41.55%-12.62M
Net income continuous Operations
21.62%-12.33M
17.94%-13.61M
44.05%-7.18M
4.45%-59.43M
-13.23%-14.29M
-0.64%-15.73M
8.00%-16.59M
19.42%-12.83M
18.98%-62.19M
41.55%-12.62M
Minority interest income
Net income attributable to the parent company
21.62%-12.33M
17.94%-13.61M
44.05%-7.18M
4.45%-59.43M
-13.23%-14.29M
-0.64%-15.73M
8.00%-16.59M
19.42%-12.83M
18.98%-62.19M
41.55%-12.62M
Preferred stock dividends
94.37%2.28M
-614.84%-8.71M
2.03M
148.57%4.08M
360.75%1.22M
137.25%1.17M
290.53%1.69M
1.64M
265K
Other preferred stock dividends
Net income attributable to common stockholders
13.58%-14.61M
73.17%-4.9M
28.19%-9.21M
0.51%-63.51M
-20.37%-15.51M
-4.82%-16.9M
1.00%-18.28M
21.64%-12.83M
16.84%-63.84M
35.80%-12.88M
Basic earnings per share
48.98%-0.25
86.21%-0.08
55.56%-0.2
24.02%-1.93
21.15%-0.41
23.44%-0.49
21.62%-0.58
-160.81%-0.45
37.59%-2.54
52.29%-0.52
Diluted earnings per share
48.98%-0.25
86.21%-0.08
55.56%-0.2
24.02%-1.93
21.15%-0.41
23.44%-0.49
21.62%-0.58
-160.81%-0.45
37.59%-2.54
52.29%-0.52
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 111.00%7.42M1.67%6.26M-18.50%5.76M-26.41%20.35M-46.89%3.62M-46.74%3.52M-0.50%6.15M-12.33%7.07M34.82%27.66M12.96%6.81M
Operating revenue 111.00%7.42M1.67%6.26M-18.50%5.76M-26.41%20.35M-46.89%3.62M-46.74%3.52M-0.50%6.15M-12.33%7.07M34.82%27.66M12.96%6.81M
Cost of revenue 21.94%3.55M-14.20%3.5M-14.67%3.33M-20.18%14.37M-14.55%3.48M-39.48%2.91M-19.17%4.08M-4.30%3.9M8.77%18M-25.60%4.08M
Gross profit 535.57%3.88M32.88%2.76M-23.23%2.43M-38.02%5.98M-95.17%132K-66.11%610K82.25%2.07M-20.52%3.17M143.63%9.66M398.54%2.73M
Operating expense -1.54%15.91M17.73%18.95M30.25%20.29M-6.46%62.17M22.19%14.35M-1.33%16.16M-12.97%16.09M-21.56%15.58M-17.39%66.47M-47.14%11.74M
Selling and administrative expenses -0.29%10.46M11.64%12.14M31.06%13.65M-10.45%41.93M45.85%10.15M-9.33%10.49M-24.27%10.87M-25.26%10.41M-25.97%46.82M-58.81%6.96M
-Selling and marketing expense 5.81%6.73M10.40%7.13M8.99%6.91M-21.56%23.79M17.91%4.62M-15.96%6.36M-30.52%6.46M-33.51%6.34M-23.63%30.32M-67.95%3.92M
-General and administrative expense -9.69%3.73M13.44%5.01M65.44%6.74M9.99%18.14M81.88%5.53M3.23%4.13M-12.79%4.41M-7.37%4.07M-29.91%16.49M-34.86%3.04M
Research and development costs -3.87%5.45M30.41%6.81M28.60%6.64M3.05%20.25M-12.25%4.2M17.95%5.67M26.23%5.22M-12.86%5.17M14.11%19.65M-10.05%4.78M
Operating profit 22.62%-12.03M-15.49%-16.19M-43.90%-17.86M1.09%-56.19M-57.77%-14.22M-6.68%-15.55M19.22%-14.02M21.82%-12.41M25.73%-56.81M58.41%-9.01M
Net non-operating interest income expense -68.28%-313K200.62%2.58M7.83%-530K156.18%1.22M394.39%4.78M82.44%-186K-281.70%-2.57M-2,513.64%-575K-5,342.50%-2.18M-10,037.50%-1.62M
Non-operating interest income --------16.42%390K269.17%1.87M69.06%470K--------8,275.00%335K1,050.00%506K3,375.00%278K
Non-operating interest expense --------------0------------------1.88M----
Total other finance cost 68.28%313K-200.62%-2.58M1.10%920K-20.07%645K-18,037.50%-4.31M-82.44%186K281.70%2.57M3,400.00%910K860.71%807K0.00%24K
Other net income (expense) 5,732.91%9.22M-37.32%-4.4M-141.22%-4.78M818.18%158K-1,542.05%-3.2M-1,660.63%-1.98M
Gain on sale of security --------5,732.91%9.22M-37.32%-4.4M-141.22%-4.78M--------818.18%158K-1,542.05%-3.2M-1,660.63%-1.98M
Income before tax 21.54%-12.34M17.94%-13.61M28.51%-9.17M4.54%-59.36M-12.75%-14.22M-0.64%-15.73M8.00%-16.59M19.42%-12.83M18.95%-62.19M41.48%-12.61M
Income tax -13K0-1.99M1,500.00%64K2,033.33%64K000-87.50%4K-90.63%3K
Net income 21.62%-12.33M17.94%-13.61M44.05%-7.18M4.45%-59.43M-13.23%-14.29M-0.64%-15.73M8.00%-16.59M19.42%-12.83M18.98%-62.19M41.55%-12.62M
Net income continuous Operations 21.62%-12.33M17.94%-13.61M44.05%-7.18M4.45%-59.43M-13.23%-14.29M-0.64%-15.73M8.00%-16.59M19.42%-12.83M18.98%-62.19M41.55%-12.62M
Minority interest income
Net income attributable to the parent company 21.62%-12.33M17.94%-13.61M44.05%-7.18M4.45%-59.43M-13.23%-14.29M-0.64%-15.73M8.00%-16.59M19.42%-12.83M18.98%-62.19M41.55%-12.62M
Preferred stock dividends 94.37%2.28M-614.84%-8.71M2.03M148.57%4.08M360.75%1.22M137.25%1.17M290.53%1.69M1.64M265K
Other preferred stock dividends
Net income attributable to common stockholders 13.58%-14.61M73.17%-4.9M28.19%-9.21M0.51%-63.51M-20.37%-15.51M-4.82%-16.9M1.00%-18.28M21.64%-12.83M16.84%-63.84M35.80%-12.88M
Basic earnings per share 48.98%-0.2586.21%-0.0855.56%-0.224.02%-1.9321.15%-0.4123.44%-0.4921.62%-0.58-160.81%-0.4537.59%-2.5452.29%-0.52
Diluted earnings per share 48.98%-0.2586.21%-0.0855.56%-0.224.02%-1.9321.15%-0.4123.44%-0.4921.62%-0.58-160.81%-0.4537.59%-2.5452.29%-0.52
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data